Viral and Non-Viral Vectors Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Viral and Non-Viral Vectors Market 

5.1. COVID-19 Landscape: Viral and Non-Viral Vectors Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Viral and Non-Viral Vectors Market, By Vector Type

8.1. Viral and Non-Viral Vectors Market, by Vector Type

8.1.1. Viral Vectors (AAV, Lentivirus, Retrovirus, Adenovirus)

8.1.1.1. Market Revenue and Forecast  

8.1.2. Non-Viral Vectors (Lipid-based, Polymer-based, Electroporation, Nanoparticles)

8.1.2.1. Market Revenue and Forecast  

Chapter 9. Global Viral and Non-Viral Vectors Market, By Application

9.1. Viral and Non-Viral Vectors Market, by Application

9.1.1. Gene Therapy

9.1.1.1. Market Revenue and Forecast  

9.1.2. Cell Therapy (CAR-T, TCR-T, Stem Cells)

9.1.2.1. Market Revenue and Forecast  

9.1.3. Vaccines (DNA, mRNA, Viral Vector Vaccines)

9.1.3.1. Market Revenue and Forecast  

9.1.4. Genetic Research & Functional Genomics

9.1.4.1. Market Revenue and Forecast  

Chapter 10. Global Viral and Non-Viral Vectors Market, By Disease Indication

10.1. Viral and Non-Viral Vectors Market, by Disease Indication

10.1.1. Oncology

10.1.1.1. Market Revenue and Forecast  

10.1.2. Rare Genetic Disorders

10.1.2.1. Market Revenue and Forecast  

10.1.3. Infectious Diseases

10.1.3.1. Market Revenue and Forecast  

10.1.4. Cardiovascular Diseases

10.1.4.1. Market Revenue and Forecast  

10.1.5. Neurological Disorders

10.1.5.1. Market Revenue and Forecast  

Chapter 11. Global Viral and Non-Viral Vectors Market, By End-Use

11.1. Viral and Non-Viral Vectors Market, by End-Use

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Forecast  

11.1.2. Academic & Research Institutes

11.1.2.1. Market Revenue and Forecast  

11.1.3. Contract Research & Manufacturing Organizations (CROs/CDMOs)

11.1.3.1. Market Revenue and Forecast  

Chapter 12. Global Viral and Non-Viral Vectors Market, By Delivery Mode

12.1. Viral and Non-Viral Vectors Market, by Delivery Mode

12.1.1. In Vivo Gene Delivery

12.1.1.1. Market Revenue and Forecast  

12.1.2. Ex Vivo Gene Delivery

12.1.2.1. Market Revenue and Forecast  

Chapter 13. Global Viral and Non-Viral Vectors Market, By Manufacturing Type

13.1. Viral and Non-Viral Vectors Market, by Manufacturing Type

13.1.1. In-house Manufacturing

13.1.1.1. Market Revenue and Forecast  

13.1.2. Contract Manufacturing (CDMO-based)

13.1.2.1. Market Revenue and Forecast  

Chapter 14. Global Viral and Non-Viral Vectors Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Vector Type  

14.1.2. Market Revenue and Forecast, by Application  

14.1.3. Market Revenue and Forecast, by Disease Indication  

14.1.4. Market Revenue and Forecast, by End-Use  

14.1.5. Market Revenue and Forecast, by Delivery Mode  

14.1.6. Market Revenue and Forecast, by Manufacturing Type  

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Vector Type  

14.1.7.2. Market Revenue and Forecast, by Application  

14.1.7.3. Market Revenue and Forecast, by Disease Indication  

14.1.7.4. Market Revenue and Forecast, by End-Use  

14.1.8. Market Revenue and Forecast, by Delivery Mode  

14.1.8.1. Market Revenue and Forecast, by Manufacturing Type   

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Vector Type  

14.1.9.2. Market Revenue and Forecast, by Application  

14.1.9.3. Market Revenue and Forecast, by Disease Indication  

14.1.9.4. Market Revenue and Forecast, by End-Use  

14.1.10. Market Revenue and Forecast, by Delivery Mode  

14.1.11. Market Revenue and Forecast, by Manufacturing Type  

14.2. Europe

14.2.1. Market Revenue and Forecast, by Vector Type  

14.2.2. Market Revenue and Forecast, by Application  

14.2.3. Market Revenue and Forecast, by Disease Indication  

14.2.4. Market Revenue and Forecast, by End-Use   

14.2.5. Market Revenue and Forecast, by Delivery Mode  

14.2.6. Market Revenue and Forecast, by Manufacturing Type  

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Vector Type  

14.2.8.2. Market Revenue and Forecast, by Application  

14.2.8.3. Market Revenue and Forecast, by Disease Indication  

14.2.9. Market Revenue and Forecast, by End-Use   

14.2.10. Market Revenue and Forecast, by Delivery Mode  

14.2.10.1. Market Revenue and Forecast, by Manufacturing Type   

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Vector Type  

14.2.11.2. Market Revenue and Forecast, by Application  

14.2.11.3. Market Revenue and Forecast, by Disease Indication  

14.2.12. Market Revenue and Forecast, by End-Use  

14.2.13. Market Revenue and Forecast, by Delivery Mode  

14.2.14. Market Revenue and Forecast, by Manufacturing Type  

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Vector Type  

14.2.15.2. Market Revenue and Forecast, by Application  

14.2.15.3. Market Revenue and Forecast, by Disease Indication  

14.2.15.4. Market Revenue and Forecast, by End-Use  

14.2.16. Market Revenue and Forecast, by Delivery Mode  

14.2.16.1. Market Revenue and Forecast, by Manufacturing Type  

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Vector Type  

14.2.17.2. Market Revenue and Forecast, by Application  

14.2.17.3. Market Revenue and Forecast, by Disease Indication  

14.2.17.4. Market Revenue and Forecast, by End-Use  

14.2.18. Market Revenue and Forecast, by Delivery Mode  

14.2.18.1. Market Revenue and Forecast, by Manufacturing Type  

14.3. APAC

14.3.1. Market Revenue and Forecast, by Vector Type  

14.3.2. Market Revenue and Forecast, by Application  

14.3.3. Market Revenue and Forecast, by Disease Indication  

14.3.4. Market Revenue and Forecast, by End-Use  

14.3.5. Market Revenue and Forecast, by Delivery Mode  

14.3.6. Market Revenue and Forecast, by Manufacturing Type  

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Vector Type  

14.3.7.2. Market Revenue and Forecast, by Application  

14.3.7.3. Market Revenue and Forecast, by Disease Indication  

14.3.7.4. Market Revenue and Forecast, by End-Use  

14.3.8. Market Revenue and Forecast, by Delivery Mode  

14.3.9. Market Revenue and Forecast, by Manufacturing Type  

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Vector Type  

14.3.10.2. Market Revenue and Forecast, by Application  

14.3.10.3. Market Revenue and Forecast, by Disease Indication  

14.3.10.4. Market Revenue and Forecast, by End-Use  

14.3.11. Market Revenue and Forecast, by Delivery Mode  

14.3.11.1. Market Revenue and Forecast, by Manufacturing Type  

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Vector Type  

14.3.12.2. Market Revenue and Forecast, by Application  

14.3.12.3. Market Revenue and Forecast, by Disease Indication  

14.3.12.4. Market Revenue and Forecast, by End-Use  

14.3.12.5. Market Revenue and Forecast, by Delivery Mode  

14.3.12.6. Market Revenue and Forecast, by Manufacturing Type  

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Vector Type  

14.3.13.2. Market Revenue and Forecast, by Application  

14.3.13.3. Market Revenue and Forecast, by Disease Indication  

14.3.13.4. Market Revenue and Forecast, by End-Use  

14.3.13.5. Market Revenue and Forecast, by Delivery Mode  

14.3.13.6. Market Revenue and Forecast, by Manufacturing Type  

14.4. MEA

14.4.1. Market Revenue and Forecast, by Vector Type  

14.4.2. Market Revenue and Forecast, by Application  

14.4.3. Market Revenue and Forecast, by Disease Indication  

14.4.4. Market Revenue and Forecast, by End-Use  

14.4.5. Market Revenue and Forecast, by Delivery Mode  

14.4.6. Market Revenue and Forecast, by Manufacturing Type  

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Vector Type  

14.4.7.2. Market Revenue and Forecast, by Application  

14.4.7.3. Market Revenue and Forecast, by Disease Indication  

14.4.7.4. Market Revenue and Forecast, by End-Use  

14.4.8. Market Revenue and Forecast, by Delivery Mode  

14.4.9. Market Revenue and Forecast, by Manufacturing Type  

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Vector Type  

14.4.10.2. Market Revenue and Forecast, by Application  

14.4.10.3. Market Revenue and Forecast, by Disease Indication  

14.4.10.4. Market Revenue and Forecast, by End-Use  

14.4.11. Market Revenue and Forecast, by Delivery Mode  

14.4.12. Market Revenue and Forecast, by Manufacturing Type  

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Vector Type  

14.4.13.2. Market Revenue and Forecast, by Application  

14.4.13.3. Market Revenue and Forecast, by Disease Indication  

14.4.13.4. Market Revenue and Forecast, by End-Use  

14.4.13.5. Market Revenue and Forecast, by Delivery Mode  

14.4.13.6. Market Revenue and Forecast, by Manufacturing Type  

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Vector Type  

14.4.14.2. Market Revenue and Forecast, by Application  

14.4.14.3. Market Revenue and Forecast, by Disease Indication  

14.4.14.4. Market Revenue and Forecast, by End-Use  

14.4.14.5. Market Revenue and Forecast, by Delivery Mode  

14.4.14.6. Market Revenue and Forecast, by Manufacturing Type  

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Vector Type  

14.5.2. Market Revenue and Forecast, by Application  

14.5.3. Market Revenue and Forecast, by Disease Indication  

14.5.4. Market Revenue and Forecast, by End-Use  

14.5.5. Market Revenue and Forecast, by Delivery Mode  

14.5.6. Market Revenue and Forecast, by Manufacturing Type  

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Vector Type  

14.5.7.2. Market Revenue and Forecast, by Application  

14.5.7.3. Market Revenue and Forecast, by Disease Indication  

14.5.7.4. Market Revenue and Forecast, by End-Use  

14.5.8. Market Revenue and Forecast, by Delivery Mode  

14.5.8.1. Market Revenue and Forecast, by Manufacturing Type  

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Vector Type  

14.5.9.2. Market Revenue and Forecast, by Application  

14.5.9.3. Market Revenue and Forecast, by Disease Indication  

14.5.9.4. Market Revenue and Forecast, by End-Use  

14.5.9.5. Market Revenue and Forecast, by Delivery Mode  

14.5.9.6. Market Revenue and Forecast, by Manufacturing Type  

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Lonza Group AG

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Catalent, Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. WuXi AppTec

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Oxford Biomedica plc

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. FUJIFILM Diosynth Biotechnologies

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Samsung Biologics

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Sartorius AG

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Charles River Laboratories International, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Takara Bio Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms